Cardiovascular Fat, Menopause, and Sex Hormones in Women: The SWAN Cardiovascular Fat Ancillary Study
- PMID: 26176800
- PMCID: PMC4570161
- DOI: 10.1210/JC.2015-2110
Cardiovascular Fat, Menopause, and Sex Hormones in Women: The SWAN Cardiovascular Fat Ancillary Study
Abstract
Context: Cardiovascular risk increases in women after menopause. Mounting evidence demonstrates a role of cardiovascular fat (CF) in the pathogenesis of coronary heart disease, but no research has examined CF in relation to sex hormones or menopausal status in women.
Objective: The objective was to determine the relationship between CF depots, menopausal status, and endogenous sex hormones.
Design: Cross-sectional and longitudinal study designs were used.
Setting: The setting included the Study of Women's Health Across the Nation (SWAN) Heart and Cardiovascular Fat Ancillary Study.
Participants: A total of 456 women (mean age, 50.75 y); 62% premenopausal/early perimenopausal, and 38% late peri-/postmenopausal.
Intervention: Menopausal status, endogenous sex hormones measured simultaneously with CF volumes, and circulating estradiol available 4.80 years (median) before CF measures.
Main outcome measures: Volumes of CF (epicardial adipose tissue [EAT], paracardial adipose tissue [PAT], total heart adipose tissue [TAT = EAT + PAT], and aortic perivascular adipose tissue [PVAT]).
Results: In final models, late peri-/postmenopausal women had 9.88% more EAT, 20.72% more PAT, and 11.69% more TAT volumes than pre-/early perimenopausal women (P < .05). PVAT was not associated with menopausal status. In final models, lower estradiol concentrations were associated with greater volumes of PAT and TAT (P < .05). Women with the greatest reduction in estradiol since baseline had greater volumes of PAT compared to women with the least reduction (P = .02).
Conclusions: Late peri-/postmenopausal women have greater volumes of heart fat compared with pre-/early perimenopausal women independent of age, obesity, and other covariates. Endogenous sex hormones are associated with CF. Perhaps CF plays a role in the higher risk of coronary heart disease reported in women after menopause.
Figures


Similar articles
-
Postmenopausal Women With Greater Paracardial Fat Have More Coronary Artery Calcification Than Premenopausal Women: The Study of Women's Health Across the Nation (SWAN) Cardiovascular Fat Ancillary Study.J Am Heart Assoc. 2017 Jan 29;6(2):e004545. doi: 10.1161/JAHA.116.004545. J Am Heart Assoc. 2017. PMID: 28137715 Free PMC article.
-
Cardiovascular fat in women at midlife: effects of race, overall adiposity, and central adiposity. The SWAN Cardiovascular Fat Study.Menopause. 2018 Jan;25(1):38-45. doi: 10.1097/GME.0000000000000945. Menopause. 2018. PMID: 28763398 Free PMC article.
-
Complement proteins and arterial calcification in middle aged women: Cross-sectional effect of cardiovascular fat. The SWAN Cardiovascular Fat Ancillary Study.Atherosclerosis. 2015 Dec;243(2):533-9. doi: 10.1016/j.atherosclerosis.2015.10.095. Epub 2015 Oct 24. Atherosclerosis. 2015. PMID: 26523990 Free PMC article.
-
The menopausal transition--endocrinology.J Sex Med. 2008 Oct;5(10):2266-73. doi: 10.1111/j.1743-6109.2008.00921.x. Epub 2008 Jul 1. J Sex Med. 2008. PMID: 18624962 Review.
-
Body fat distribution, the menopause transition, and hormone replacement therapy.Diabetes Metab. 2000 Feb;26(1):12-20. Diabetes Metab. 2000. Retraction in: Diabetes Metab. 2006 Jun;32(3):285. doi: 10.1016/s1262-3636(07)70282-3. PMID: 10705099 Retracted. Review.
Cited by
-
Pregnancy and Reproductive Risk Factors for Cardiovascular Disease in Women.Circ Res. 2022 Feb 18;130(4):652-672. doi: 10.1161/CIRCRESAHA.121.319895. Epub 2022 Feb 17. Circ Res. 2022. PMID: 35175837 Free PMC article. Review.
-
Weight, Shape, and Body Composition Changes at Menopause.J Midlife Health. 2021 Jul-Sep;12(3):187-192. doi: 10.4103/jmh.jmh_123_21. Epub 2021 Oct 16. J Midlife Health. 2021. PMID: 34759699 Free PMC article.
-
U-shaped association between the triglyceride-glucose index and atrial fibrillation incidence in a general population without known cardiovascular disease.Cardiovasc Diabetol. 2023 May 18;22(1):118. doi: 10.1186/s12933-023-01777-9. Cardiovasc Diabetol. 2023. PMID: 37208737 Free PMC article.
-
Effects of Hormone Therapy on Heart Fat and Coronary Artery Calcification Progression: Secondary Analysis From the KEEPS Trial.J Am Heart Assoc. 2019 Aug 6;8(15):e012763. doi: 10.1161/JAHA.119.012763. Epub 2019 Aug 1. J Am Heart Assoc. 2019. PMID: 31652073 Free PMC article. Clinical Trial.
-
Gonadotropin-releasing hormone agonist treatment and ischemic heart disease among female patients with breast cancer: A cohort study.Cancer Med. 2023 Mar;12(5):5536-5544. doi: 10.1002/cam4.5390. Epub 2022 Oct 28. Cancer Med. 2023. PMID: 36305849 Free PMC article.
References
-
- Davis SR, Castelo-Branco C, Chedraui P, et al. Understanding weight gain at menopause. Climacteric. 2012;15:419–429. - PubMed
-
- Wing RR, Matthews KA, Kuller LH, Meilahn EN, Plantinga PL. Weight gain at the time of menopause. Arch Intern Med. 1991;151:97–102. - PubMed
-
- Guthrie JR, Dennerstein L, Dudley EC. Weight gain and the menopause: a 5-year prospective study. Climacteric. 1999;2:205–211. - PubMed
-
- Abdulnour J, Doucet E, Brochu M, et al. The effect of the menopausal transition on body composition and cardiometabolic risk factors: a Montreal-Ottawa New Emerging Team group study. Menopause. 2012;19:760–767. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- P60 MD003422/MD/NIMHD NIH HHS/United States
- U01 AG012554/AG/NIA NIH HHS/United States
- R01 HL065591/HL/NHLBI NIH HHS/United States
- R01 HL065581/HL/NHLBI NIH HHS/United States
- U01 AG012535/AG/NIA NIH HHS/United States
- U01 AG012553/AG/NIA NIH HHS/United States
- U01 NR004061/NR/NINR NIH HHS/United States
- U01 AG012539/AG/NIA NIH HHS/United States
- U01 AG012546/AG/NIA NIH HHS/United States
- U01 AG012495/AG/NIA NIH HHS/United States
- U01 AG012505/AG/NIA NIH HHS/United States
- U01 AG012531/AG/NIA NIH HHS/United States
- T32 HL083825/HL/NHLBI NIH HHS/United States